Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Microbial cell wall/protein disruption" does not refer to a specific single molecular target, receptor, or protein; instead, it describes a broad range of structural elements (such as the bacterial or fungal cell wall) and the physical or chemical processes used to break these structures to access intracellular proteins and other biomolecules. The **cell wall** is a rigid, dynamic structure primarily composed of peptidoglycan in bacteria, glucan in fungi, and other polysaccharides, providing mechanical strength and protection from osmotic pressure. Disruption of this wall, often for protein extraction, can be achieved by mechanical means (homogenization, bead milling), chemical agents (detergents, alkali, EDTA), physical methods (sonication, thermal shock), or enzymatic lysis (lysozyme, proteases). These methods are fundamental for biotechnology and microbiology applications including protein purification, but do not describe a discrete "therapeutic target" in the pharmacological sense[2][3][5][6]. In therapeutics, several antibiotics exploit this vulnerability by specifically inhibiting the biosynthesis of cell wall components, leading to lysis and death of the microbe[1][3]. However, the term itself is overly broad and non-specific as a target name and should be mapped to precise molecular targets (e.g., "Peptidoglycan glycosyltransferase," "Penicillin-binding protein 2a," "Lysozyme") for structured drug discovery or therapeutic databases.
Inhibition of cell wall biosynthesis (e.g., β-lactams targeting peptidoglycan synthesis) - Direct wall lysis/disruption (mechanical, chemical, enzymatic) - Permeabilization for content release (e.g., detergents, EDTA) - Degradation of cell wall structures[1][2][3][5][6]
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell wall and protein.